Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

First human receives reverse-aging gene therapy in groundbreaking trial targeting glaucoma, using cellular reprogramming to ...

A groundbreaking discovery led scientists to create a world's first - a drug that can reverse the signs of biological aging.

The approach relies on “reprogramming” cells to a younger state. It’s one of many strategies being explored by biotech ...

Test time has arrived: the first person has been treated in a highly anticipated gene therapy trial that aims to coax aged ...

In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the "recipe" for the transformation. Researchers at Lund University have now created ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in pancreatic cancer—and identified a promising strategy to overcome that resistance.

The world's first reverse aging drug, ER-100, was injected into a human on June 9, 2026 The post The World’s First ...

A participant in a landmark clinical trial has been given a cellular-reprogramming treatment that aims to rejuvenate damaged ...